TransMed7 is delighted to announce the ongoing production of prototype HeronTM devices for its newly announced Project Company, Heron MD, LLC. Annually
TransMed7’s Intellectual Property portfolio is built on a robust patent generation and protection strategy, developed and backed by deep expertise with our
We were delighted to present several prototype CardinalTM devices for the first time at this year’s ASBrS meeting. As expected, there was
The TransMed7 team was most delighted to initiate the “soft” launch of its primary breast platform devices, SpeedBirdTM and ConcordeTM including SpeedBird
TransMed7, LLC announced today the availability of Concorde, the stereotactic table variant of its SpeedBird Biopsy Device Platform “We are delighted
TransMed7, LLC Announces 510(k) Clearance by the U.S. FDA for its SpeedBird Soft Tissue Biopsy Device Platform TransMed7, LLC announced today